Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Get Alerts GILD Hot Sheet
Price: $67.36 +0.61%
Revenue Growth %: -0.6%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: -0.6%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Spotify (SPOT) jumps 10% as Q1 revenue, gross margins beat Street's estimates
- BCB Bancorp (BCBP) PT Lowered to $12 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!